- Report
- January 2026
- 180 Pages
Global
From €3977EUR$4,500USD£3,444GBP
- Report
- May 2026
- 465 Pages
Global
From €5170EUR$5,850USD£4,477GBP
- Report
- September 2025
- 270 Pages
Global
From €4414EUR$4,995USD£3,823GBP
- Report
- January 2026
- 189 Pages
Global
From €3133EUR$3,545USD£2,713GBP
€3481EUR$3,939USD£3,015GBP
- Report
- February 2026
- 250 Pages
Global
From €3968EUR$4,490USD£3,436GBP
- Report
- July 2023
- 200 Pages
Global
From €4109EUR$4,650USD£3,559GBP
- Report
- October 2023
- 120 Pages
Global
From €5258EUR$5,950USD£4,554GBP
- Report
- October 2023
- 117 Pages
Global
From €3977EUR$4,500USD£3,444GBP
- Report
- March 2024
- 132 Pages
Global
From €839EUR$950USD£727GBP
- Report
- November 2021
- 527 Pages
Global
From €3535EUR$4,000USD£3,061GBP
The miRNA Sequencing market is a subset of the larger genomics market. It is focused on the sequencing of microRNAs, which are small, non-coding RNA molecules that regulate gene expression. miRNA sequencing is used to identify and quantify miRNAs in a sample, and can be used to study gene expression, disease diagnosis, and drug development.
miRNA sequencing is a rapidly growing field, with a variety of companies offering services and products. These include Illumina, Thermo Fisher Scientific, Agilent Technologies, Bio-Rad Laboratories, and QIAGEN. Show Less Read more